The Asia Pacific Hernia Mesh Devices Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 1,221.8 thousand units, showcasing a growth of 9.0% (2019-2022).
The high prevalence of hernia and improved patient outcomes through meshes, reducing operative and recovery time, contribute to the expansion of the market. The high incidence rate of hernia generates demand for effective hernia mesh devices, which is anticipated to drive market expansion. In addition, using meshes in hernia repair reduces the possibility of recurrence and alleviates pain, which is anticipated to accelerate market growth.
Hernia mesh device advancements in technology have accelerated in recent years. To address the issues that arise during the laparoscopic procedure advances such as articulating fixation devices and self-fixating (gripping) mesh are being developed. In addition, these devices provide surgeons with improved access to abdominal wall weak spots and the ability to securely position mesh at the desired body site, thereby fostering market expansion.
The utilization of 3D printing technology has enabled the creation of customized hernia mesh devices tailored to the patient's specific anatomy. These devices provide an optimal fit, reducing the risk of complications. Biologic meshes, derived from natural sources such as porcine or bovine tissue, are gaining popularity. They have the advantage of being fully absorbed by the body over time, which lead to reduced long-term complications. Traditional fixation devices, such as sutures or tacks, can cause discomfort or complications for patients. Bioabsorbable fixation devices are becoming more common as they naturally dissolve over time, eliminating the need for removal.
As per NLM, Australia has experienced a precipitous increase in incisional and ventral hernia repair (IVHR) surgeries over the last twenty years, particularly for primary ventral hernias. The rise in IVHR surgeries has led to the development of customized mesh solutions tailored to the patient's anatomy in Australia. These personalized mesh devices aim to provide better fit and improved outcomes in Australia. Mesh manufacturers in Australia must cater to these specific requirements. As these surgeries are popular in Australia, the region will likely witness ongoing innovation, product development, and improved patient care. Due to these factors, the market in the Asia Pacific region is estimated to grow in upcoming years.
The China market dominated the Asia Pacific Hernia Mesh Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $490.6 Million by 2030. The Japan market is registering a CAGR of 7.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8.5% during (2023 - 2030).
Based on Type, the market is segmented into Synthetic and Biologic. Based on Hernia Type, the market is segmented into Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
The high prevalence of hernia and improved patient outcomes through meshes, reducing operative and recovery time, contribute to the expansion of the market. The high incidence rate of hernia generates demand for effective hernia mesh devices, which is anticipated to drive market expansion. In addition, using meshes in hernia repair reduces the possibility of recurrence and alleviates pain, which is anticipated to accelerate market growth.
Hernia mesh device advancements in technology have accelerated in recent years. To address the issues that arise during the laparoscopic procedure advances such as articulating fixation devices and self-fixating (gripping) mesh are being developed. In addition, these devices provide surgeons with improved access to abdominal wall weak spots and the ability to securely position mesh at the desired body site, thereby fostering market expansion.
The utilization of 3D printing technology has enabled the creation of customized hernia mesh devices tailored to the patient's specific anatomy. These devices provide an optimal fit, reducing the risk of complications. Biologic meshes, derived from natural sources such as porcine or bovine tissue, are gaining popularity. They have the advantage of being fully absorbed by the body over time, which lead to reduced long-term complications. Traditional fixation devices, such as sutures or tacks, can cause discomfort or complications for patients. Bioabsorbable fixation devices are becoming more common as they naturally dissolve over time, eliminating the need for removal.
As per NLM, Australia has experienced a precipitous increase in incisional and ventral hernia repair (IVHR) surgeries over the last twenty years, particularly for primary ventral hernias. The rise in IVHR surgeries has led to the development of customized mesh solutions tailored to the patient's anatomy in Australia. These personalized mesh devices aim to provide better fit and improved outcomes in Australia. Mesh manufacturers in Australia must cater to these specific requirements. As these surgeries are popular in Australia, the region will likely witness ongoing innovation, product development, and improved patient care. Due to these factors, the market in the Asia Pacific region is estimated to grow in upcoming years.
The China market dominated the Asia Pacific Hernia Mesh Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $490.6 Million by 2030. The Japan market is registering a CAGR of 7.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8.5% during (2023 - 2030).
Based on Type, the market is segmented into Synthetic and Biologic. Based on Hernia Type, the market is segmented into Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
Scope of the Study
Market Segments Covered in the Report:
By Type (Volume, thousand units, USD Million, 2019-2030)- Synthetic
- Biologic
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Becton Dickinson and Company
- Johnson & Johnson
- W.L. Gore & Associates, Inc.
- Atrium Medical Corporation (Getinge AB)
- B.Braun Melsungen AG
- Baxter International, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Integra LifeSciences Holdings Corporation
- Herniamesh S.r.l.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Hernia Mesh Devices Market by Type
Chapter 5. Asia Pacific Hernia Mesh Devices Market by Hernia Type
Chapter 6. Asia Pacific Hernia Mesh Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton Dickinson and Company
- Johnson & Johnson
- W. L. Gore & Associates, Inc.
- Atrium Medical Corporation (Getinge AB)
- B. Braun Melsungen AG
- Baxter International, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Integra LifeSciences Holdings Corporation
- Herniamesh S.r.l.
Methodology
LOADING...
